Cargando…

Research priorities for rare neurological diseases: a representative view of patient representatives and healthcare professionals from the European Reference Network for Rare Neurological Diseases

BACKGROUND: Patient involvement in research increases the impact of research and the likelihood of adoption in clinical practice. A first step is to know which research themes are important for patients. We distributed a survey on research priorities to ERN-RND members, both patient representatives...

Descripción completa

Detalles Bibliográficos
Autores principales: Post, Annemarie E. M., Klockgether, Thomas, Landwehrmeyer, G. Bernhard, Pandolfo, Massimo, Arnesen, Astri, Reinhard, Carola, Graessner, Holm
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7976714/
https://www.ncbi.nlm.nih.gov/pubmed/33736655
http://dx.doi.org/10.1186/s13023-020-01641-z
_version_ 1783667051502501888
author Post, Annemarie E. M.
Klockgether, Thomas
Landwehrmeyer, G. Bernhard
Pandolfo, Massimo
Arnesen, Astri
Reinhard, Carola
Graessner, Holm
author_facet Post, Annemarie E. M.
Klockgether, Thomas
Landwehrmeyer, G. Bernhard
Pandolfo, Massimo
Arnesen, Astri
Reinhard, Carola
Graessner, Holm
author_sort Post, Annemarie E. M.
collection PubMed
description BACKGROUND: Patient involvement in research increases the impact of research and the likelihood of adoption in clinical practice. A first step is to know which research themes are important for patients. We distributed a survey on research priorities to ERN-RND members, both patient representatives and healthcare professionals, asking them to prioritize five research themes for rare neurological diseases on a scale ranging from 1 (most important) to 5 (least important). A follow-up e-mail interview was conducted with patient representatives and professionals to assess potential reasons for differences in opinions between these two groups. RESULTS: In total, 156 responses were analysed: 61 from professionals and 95 from patient representatives. They covered all ERN-RND disease groups and came from 20 different EU countries. Almost half of the respondents considered ‘Developing therapies and preventive strategies’ the most important research theme. In particular, patient representatives prioritized this theme more often than professionals, while professionals prioritized ‘Disease mechanisms and models’. Patient representatives indicated that therapies and prevention were of the utmost importance to them, because their lives are often heavily impacted by the disease and their main goal is to relief the burden of disease. Professionals indicated that investigating disease mechanisms will lead to more knowledge and is indispensable for finding new treatments. CONCLUSIONS: Patients and professionals have different opinions on which research theme should have priority. A qualitative follow-up shows that they respect each others’ view points. Different stakeholders involved in research should be aware of their differences in research theme priority. Explaining these differences to each other leads to more understanding, and could improve patient engagement in research. GRAPHICAL ABSTRACT: [Image: see text]
format Online
Article
Text
id pubmed-7976714
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-79767142021-03-19 Research priorities for rare neurological diseases: a representative view of patient representatives and healthcare professionals from the European Reference Network for Rare Neurological Diseases Post, Annemarie E. M. Klockgether, Thomas Landwehrmeyer, G. Bernhard Pandolfo, Massimo Arnesen, Astri Reinhard, Carola Graessner, Holm Orphanet J Rare Dis Research BACKGROUND: Patient involvement in research increases the impact of research and the likelihood of adoption in clinical practice. A first step is to know which research themes are important for patients. We distributed a survey on research priorities to ERN-RND members, both patient representatives and healthcare professionals, asking them to prioritize five research themes for rare neurological diseases on a scale ranging from 1 (most important) to 5 (least important). A follow-up e-mail interview was conducted with patient representatives and professionals to assess potential reasons for differences in opinions between these two groups. RESULTS: In total, 156 responses were analysed: 61 from professionals and 95 from patient representatives. They covered all ERN-RND disease groups and came from 20 different EU countries. Almost half of the respondents considered ‘Developing therapies and preventive strategies’ the most important research theme. In particular, patient representatives prioritized this theme more often than professionals, while professionals prioritized ‘Disease mechanisms and models’. Patient representatives indicated that therapies and prevention were of the utmost importance to them, because their lives are often heavily impacted by the disease and their main goal is to relief the burden of disease. Professionals indicated that investigating disease mechanisms will lead to more knowledge and is indispensable for finding new treatments. CONCLUSIONS: Patients and professionals have different opinions on which research theme should have priority. A qualitative follow-up shows that they respect each others’ view points. Different stakeholders involved in research should be aware of their differences in research theme priority. Explaining these differences to each other leads to more understanding, and could improve patient engagement in research. GRAPHICAL ABSTRACT: [Image: see text] BioMed Central 2021-03-18 /pmc/articles/PMC7976714/ /pubmed/33736655 http://dx.doi.org/10.1186/s13023-020-01641-z Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Post, Annemarie E. M.
Klockgether, Thomas
Landwehrmeyer, G. Bernhard
Pandolfo, Massimo
Arnesen, Astri
Reinhard, Carola
Graessner, Holm
Research priorities for rare neurological diseases: a representative view of patient representatives and healthcare professionals from the European Reference Network for Rare Neurological Diseases
title Research priorities for rare neurological diseases: a representative view of patient representatives and healthcare professionals from the European Reference Network for Rare Neurological Diseases
title_full Research priorities for rare neurological diseases: a representative view of patient representatives and healthcare professionals from the European Reference Network for Rare Neurological Diseases
title_fullStr Research priorities for rare neurological diseases: a representative view of patient representatives and healthcare professionals from the European Reference Network for Rare Neurological Diseases
title_full_unstemmed Research priorities for rare neurological diseases: a representative view of patient representatives and healthcare professionals from the European Reference Network for Rare Neurological Diseases
title_short Research priorities for rare neurological diseases: a representative view of patient representatives and healthcare professionals from the European Reference Network for Rare Neurological Diseases
title_sort research priorities for rare neurological diseases: a representative view of patient representatives and healthcare professionals from the european reference network for rare neurological diseases
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7976714/
https://www.ncbi.nlm.nih.gov/pubmed/33736655
http://dx.doi.org/10.1186/s13023-020-01641-z
work_keys_str_mv AT postannemarieem researchprioritiesforrareneurologicaldiseasesarepresentativeviewofpatientrepresentativesandhealthcareprofessionalsfromtheeuropeanreferencenetworkforrareneurologicaldiseases
AT klockgetherthomas researchprioritiesforrareneurologicaldiseasesarepresentativeviewofpatientrepresentativesandhealthcareprofessionalsfromtheeuropeanreferencenetworkforrareneurologicaldiseases
AT landwehrmeyergbernhard researchprioritiesforrareneurologicaldiseasesarepresentativeviewofpatientrepresentativesandhealthcareprofessionalsfromtheeuropeanreferencenetworkforrareneurologicaldiseases
AT pandolfomassimo researchprioritiesforrareneurologicaldiseasesarepresentativeviewofpatientrepresentativesandhealthcareprofessionalsfromtheeuropeanreferencenetworkforrareneurologicaldiseases
AT arnesenastri researchprioritiesforrareneurologicaldiseasesarepresentativeviewofpatientrepresentativesandhealthcareprofessionalsfromtheeuropeanreferencenetworkforrareneurologicaldiseases
AT reinhardcarola researchprioritiesforrareneurologicaldiseasesarepresentativeviewofpatientrepresentativesandhealthcareprofessionalsfromtheeuropeanreferencenetworkforrareneurologicaldiseases
AT graessnerholm researchprioritiesforrareneurologicaldiseasesarepresentativeviewofpatientrepresentativesandhealthcareprofessionalsfromtheeuropeanreferencenetworkforrareneurologicaldiseases